PARTNER PROGRAM SPONSOR
12:30 – 1:30PM
THURSDAY 16 JUNE
LUNCH & LEARN SESSION 1
POC high sensitivity troponin: Is there a role in the ED?
The use of a point-of-care, high-sensitivity cardiac troponin assay in the Emergency Department to assist in the early diagnosis of myocardial infarction: clinical considerations, economic impact and future opportunities.
Chair: Prof Louise Cullen
Speakers:
Access block in ED, future forecast, Dr Martin Than
Analytical performance of the VTLi hs-cTnI assay, Prof Richard Body
The value of time, current assays in the market, Dr Frank Peacock
Speaker: Dr Martin Than
With a career in medicine spanning 30 years, Dr Than has been an Emergency Medicine Specialist in Christchurch, New Zealand since 2001. For the past 15 years he has undertaken significant research projects, with a focus on knowledge translation that makes meaningful clinical impact. He is Director of Emergency Medicine Research in Christchurch Hospital and has been awarded multiple grants by the New Zealand Health Research Council including a 5-year Clinical Practitioner Research Fellowship.
Dr Than has participated in many committees and advisory boards including the IFCC Committee on the Clinical Application of Cardiac Biomarkers that created the definition of high sensitivity troponin.
Dr Than’s profound interest in supporting and monitoring research that improves patient care safely and ethically drives him to participate in any forums with aligned aims. He has extensive international collaborative links and experience in undertaking and overseeing large research projects.
Dr Than has led the Christchurch-based research team that has undertaken a series of projects since 2007 that have changed practice across NZ hospitals and many others world-wide. The team’s projects have involved 6 major studies which have been recognised with local and international awards, most recently the 2020 International UNIVANTS of Healthcare Excellence award.
He has published 172 papers and 3 book chapters to date.
Speaker: Prof Rick Body
MB ChB, MRCSEd(A&E), FRCEM, PhD
Prof Body is a Professor of Emergency Medicine at the University of Manchester. He is also an Honorary Consultant in Emergency Medicine and the Group Director of Research & Innovation at Manchester University NHS Foundation. Prof Body is Deputy Editor at the Emergency Medicine Journal, Deputy National Specialty Lead for Trauma & Emergency Care at the NIHR National Institute of Health Research and a member of the International Federation of Clinical Chemistry Committee for Cardiac Biomarkers. His research focuses on analytical modeling, decision support, diagnostics and the design and conduct of large clinical studies. Prof. Body’s work on high-sensitivity cardiac troponin assays for early diagnosis of acute coronary syndromes has led to a number of high impact publications and widespread changes to clinical practice internationally.
Speaker: Dr Frank Peacock
MD, FACEP, FACC, FESC
Dr. Peacock is Vice Chair for Research, Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine in Houston, Texas. With over 600 publications on heart failure and acute coronary syndromes, Dr. Peacock is also the co-editor of the textbooks Cardiac Emergencies, Short Stay Management of Heart Failure, and Short Stay Management of Chest Pain. He is the 2004 and 2010 winner of the Best Research Paper Award from the American College of Emergency Physicians, the winner of the 2019 Ray Bahr Award for Excellence from the American College of Cardiology and is the Codman Award recipient from the American Association of Group Practice.
Dr. Peacock has and continues to serve as PI or co-PI for many high profile national and international clinical trials such as PRONTO, ADHERE-EM, IMPACT, CHOPIN, CLUE, FASTTRACK and TRUE-HF. His clinical interests and research focus include acute coronary syndrome, acute heart failure, biomarkers, improvements in emergency medical care, and more rapid patient disposition.
Speaker: Prof Louise Cullen
MBBS(HON), FACEM, Ph.D.
Louise Cullen is an Emergency Physician in Brisbane, Australia, a clinical trialist and outcomes researcher in acute diseases, holding the position of Professor at the University of Queensland and Adjunct Professor at Queensland University of Technology. She is enthusiastically involved in the translation of research by clinical redesign and innovation. As an accomplished acute disease research, Prof. Cullen has focused on the diagnosis and management of patients presenting with possible acute coronary syndrome (ACS) the emergency department (ED). She has been engaged in many international collaborations and has authored over 150 publications in peer-reviewed journals including the NEJM and the Lancet, focused on strategies to improve efficiency, whilst maintaining safety for patients with possible ACS, syncope, heart failure, shortness of breath and atrial fibrillation. More recently, Prof. Cullen has focused on health services research aimed at reducing unnecessary or low benefit care in the ED.
